No Data
No Data
Allmed Medical Products (002950.SZ) 2023 annual equity distribution: 0.270508 yuan per 10 shares. June 18 is the record date.
Allmed Medical Products (002950.SZ) announced that the company's annual equity distribution plan for 2023 is: based on the current...
Are Allmed Medical Products Co.,Ltd's (SZSE:002950) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?
Allmed Medical ProductsLtd (SZSE:002950) has had a rough month with its share price down 13%. We, however decided to study the company's financials to determine if they have got anything to do with
Allmed Medical Products (002950.SZ): has repurchased 1.948% of its shares.
Allmed medical products (002950.SZ) announced on June 3rd that as of May 31, 2024, the company has repurchased 12,338,110 shares through the Shenzhen Stock Exchange trading system by centralized competitive transaction mode, accounting for 1.9483% of the total share capital of the company. The highest fill price was 8.49 yuan/share, the lowest fill price was 7.04 yuan/share, and the total amount paid was 96,439,200 yuan (excluding transaction fees such as stamp duty and commission).
Ogilvy Healthcare (002950.SZ) has spent 94.4941 million yuan to buy back 1.91% of its shares
Zhitong Finance App News, Ogilvy Healthcare (002950.SZ) issued an announcement. As of April 30, 2024, the company has repurchased 12,104,960 shares of the company through centralized bidding transactions through the Shenzhen Stock Exchange trading system, accounting for 1.9115% of the company's current total share capital. The highest transaction price is 8.25 yuan/share, the minimum transaction price is 7.04 yuan/share, and the total amount paid is 94.4941 million yuan (excluding transaction fees such as stamp duty and transaction fees).
Is Allmed Medical ProductsLtd (SZSE:002950) A Risky Investment?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company is, we always like to look at its use of debt, since debt overload can lead to rui
Ogilvy Healthcare (002950.SZ): Net profit of 93.8791 million yuan for the first quarter decreased 26.59% year-on-year
Gelonghui, April 29 | Ogilvy Healthcare (002950.SZ) released its report for the first quarter of 2024. Operating revenue for the reporting period was 746 million yuan, down 8.38% year on year; net profit attributable to shareholders of listed companies was 938,791 million yuan, down 26.59% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 83,581 million yuan, down 24.48% year on year; basic earnings per share were 0.1,482 yuan.
No Data